Zepp Health (NYSE:ZEPP – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a report released on Saturday.
Separately, Fundamental Research set a $56.28 price target on Zepp Health and gave the stock a “buy” rating in a report on Wednesday, April 22nd. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $56.28.
Get Our Latest Stock Report on Zepp Health
Zepp Health Trading Up 5.4%
Insider Buying and Selling at Zepp Health
In other news, CFO Cheng Deng sold 9,836 shares of the firm’s stock in a transaction on Friday, June 26th. The stock was sold at an average price of $4.61, for a total transaction of $45,343.96. Following the sale, the chief financial officer owned 114,539 shares in the company, valued at $528,024.79. This trade represents a 7.91% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 36.00% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Zepp Health
Institutional investors have recently added to or reduced their stakes in the business. Public Employees Retirement System of Ohio increased its stake in shares of Zepp Health by 61.4% during the 4th quarter. Public Employees Retirement System of Ohio now owns 1,514 shares of the company’s stock valued at $41,000 after acquiring an additional 576 shares during the last quarter. Harvest Fund Management Co. Ltd boosted its position in shares of Zepp Health by 6.7% in the fourth quarter. Harvest Fund Management Co. Ltd now owns 44,800 shares of the company’s stock worth $1,207,000 after acquiring an additional 2,800 shares during the last quarter. Osaic Holdings Inc. boosted its position in shares of Zepp Health by 239.5% in the fourth quarter. Osaic Holdings Inc. now owns 8,285 shares of the company’s stock worth $223,000 after acquiring an additional 5,845 shares during the last quarter. Dimensional Fund Advisors LP purchased a new stake in Zepp Health in the fourth quarter valued at approximately $241,000. Finally, Capstone Capital Management Ltd acquired a new position in Zepp Health during the fourth quarter worth approximately $298,000. 52.61% of the stock is currently owned by institutional investors and hedge funds.
Zepp Health Company Profile
Zepp Health Corp is a technology company specializing in the design, development and sale of smart wearable devices and health management solutions. Through its flagship Amazfit brand and the Zepp software ecosystem, the company offers a range of products—including smartwatches, fitness bands, smart scales and health-oriented mobile applications—designed to track key biometric data such as heart rate, sleep patterns, blood oxygen levels and activity metrics. Zepp Health’s integrated platform enables users to monitor wellness and fitness goals while leveraging cloud-based analytics for personalized insights.
At the core of Zepp Health’s offering is its Zepp cloud platform, which aggregates and analyzes data collected from its hardware lineup.
See Also
- Five stocks we like better than Zepp Health
- AST SpaceMobile Stock Sinks as SpaceX Fallout Rattles Space Sector
- Aehr Test Systems Stock Soars on Earnings, Eyes Over 150% Revenue Growth
- TSMC Just Gave AI Chip Bulls Another Reason to Stay Confident
- GE Aerospace Faces a Prove-It Moment in Q2 Earnings
Receive News & Ratings for Zepp Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zepp Health and related companies with MarketBeat.com's FREE daily email newsletter.
